This report examines 35 years of cooperation between the United States and China in the areas of science and technology (S&T) since the signing of the 1979 U.S.-China Science and Technology Cooperation Agreement.
The hearing will examine economic, political, and security developments in cross-Strait and China-North Korea relations. It will assess the opportunities and risks arising from closer cross-Strait economic integration for Taiwan and the United States, and it will examine Taiwan’s ability to defend against military coercion by China. The hearing will also address whether China’s views and policies toward North Korea have changed in recent years and the implications for U.S. security interests.
This hearing will examine the legacy of the Tiananmen Square Massacre and the underlying economic, political, and social tensions that cause instability in China today, as well as the implications of these challenges for U.S. economic and security interests. The hearing will also assess China’s response to its internal security challenges, and the use of media and information controls to contain domestic unrest and manage public opinion.
This hearing will examine, among other things, China’s energy needs and clean energy policies, the recent developments in the U.S.-China clean energy cooperation, and the implications of such cooperation for the United States.
The Commission is soliciting proposals for copyediting and proofreading services until April 25, 2014, at 5:30pm EST. Please find the solicitation linked below, or at the Federal Business Opportunities website, www.FBO.gov.
This hearing will address China’s recent healthcare reforms, market access for U.S. medical goods and services in China, and the safety of medical products imported from China into the United States. China is growing more affluent and urbanized, and is also facing new healthcare challenges. The Chinese government has launched ambitious reforms to expand coverage and improve care. This hearing will consider whether U.S. drug and medical device makers are able to compete in China’s market. It will also assess the U.S. Food and Drug Administration’s ongoing efforts to regulate drugs and drug ingredients imported from China into the United States.
This hearing will explore the evolving security dynamics in Asia and the effects of this changing environment on the United States. More specifically, it will address how Northeast Asia, Southeast Asia, and Oceania are responding to China’s rise and consider what implications follow for U.S. alliances and partnerships in the region.
The U.S.-China Economic and Security Review Commission was created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.